Trial Profile
Patient-Reported Outcomes of Brimonidine Tartrate 0.5% Gel for Treatment of Severe Facial Erythema of Rosacea
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary)
- Indications Rosacea
- Focus Registrational; Therapeutic Use
- Acronyms PROOF
- Sponsors Galderma
- 24 Jan 2014 New trial record